About

About

Drivers

Partnerships

Locations

departments

Medical & Scientific

Quality Assurance

Regulatory Affairs

Pharmacovigilance

Audits

Contacts

+351 239 781 014

Chamada para rede nacional

owlpharma@owlpharma.com

Newsletter

No spam. Notifications only
aboutnew products and
updates. You can always
unsubscribe.

Obrigado! A sua submissão foi enviada com sucesso.
Oops! Parece que se passa algo de errado.
Newsletter
Newsletter

No spam. Notifications only
aboutnew products and
updates. You can always
unsubscribe.

Obrigado! A sua submissão foi enviada com sucesso.
Oops! Parece que se passa algo de errado.

Subscribe Newsletter

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Departments
Regulatory Affairs
Pharmacovigilance
Medical & Scientific
Quality Assurance
Audits
Owlpharma
knOWLedge
OWL News
Home
About Us
01
Meet the OWL
02
Video: What we do
03
Our Drivers
04
Partnerships
05
Offices
Our Team
01
Managing Team
02
Team
03
Jobs: Apply now!
Our Tools
Departments
Regulatory AffairsPharmacovigilanceMedical & ScientificQuality AssuranceAudits
Our Tools
knOWLedge
News
Contact us
16
October

Qualificação de Fornecedores – Estratégias e Desafios

See event
16
October

Qualificação de Fornecedores – Estratégias e Desafios

See event
02
October

Publicidade de Produtos de Saúde - DMs, Cosméticos e Suplementos Alimentares

See event
02
October

Publicidade de Produtos de Saúde - DMs, Cosméticos e Suplementos Alimentares

See event
See all >
Pharmacovigilance; Legislation
November 21, 2024

Risk Minimisation Measures - GVP Latest Updates

Regulatory, Legislation
November 18, 2024

Annual Price Revision for 2025

See all >
ContactsContact Us
Our newsletter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Terms of service
Privacy policy
OWL news
Discover all the Pharma updates
01

Medical & Scientific

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Learn more
02

Quality Assurance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Learn more
03

Pharmacovigilance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Learn more
04

Audits

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Learn more
05

More

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Learn more
Pharmacovigilance; Legislation
November 21, 2024
/
Sofia Santos

Risk Minimisation Measures - GVP Latest Updates

GMDP, Legislation

Heading

/
Text Link
August 29, 2022
Filter the news by category below.
Search for a specific new below or filter the news by category.
Choose Category
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
All news
Medical & Scientific
Regulatory
Pharmacovigilance
GMDP
OWL
Legislation
All news
Medical & Scientific
Regulatory
Pharmacovigilance
GMDP
OWL
Legislation
Pharmacovigilance; Legislation

Nov 21, 2024

/

Sofia Santos

Risk Minimisation Measures - GVP Latest Updates

Regulatory, Legislation

Nov 18, 2024

/

Raquel Miguéis

Annual Price Revision for 2025

OWL

Sep 17, 2024

/

Ricardo Andrade

Inauguração da nova sede

Sep 17, 2024

/

Mariana Rocha

World Patient Safety Day

November 18, 2024

/

Raquel Miguéis

Annual Price Revision for 2025

September 17, 2024

/

Mariana Rocha

World Patient Safety Day

June 13, 2024

/

Margarida Tapadas

The legal framework of medicinal cannabis in Portugal

May 20, 2024

/

Gustavo Sousa

Handling API manufacturers: Insights from the New CEFIC-APIC Guide and Owlpharma recent experience

January 31, 2024

/

Mariana Pinto

Owlpharma becomes a member of the 3PARL

November 24, 2023

/

José Gomes

GCP Audits - A new piece in our compliance puzzle

September 22, 2023

/

Mariana Silva

MDR extension period – Where do you stand now?

July 31, 2023

/

Mariana Pinto

AuditSearch - Owlpharma's new tool

October 4, 2024

/

Eva Faria

Owlpharma's Quality Management System - Certification ISO 9001:2015

September 17, 2024

/

Ricardo Andrade

Inauguração da nova sede

May 27, 2024

/

Mariana Rocha

Desafios atuais de Farmacovigilância - Edição 2024

May 17, 2024

/

André Luz

Fórum de Diretores Técnicos de Distribuição

February 23, 2024

/

Lígia Ferreira

New HMA-EMA catalogues of real-world data sources and studies

January 31, 2024

/

Mariana Pinto

Owlpharma becomes a member of the 3PARL

Pharmacovigilance; Legislation

November 21, 2024

/

Sofia Santos

Risk Minimisation Measures - GVP Latest Updates

Regulatory, Legislation

November 18, 2024

/

Raquel Miguéis

Annual Price Revision for 2025

Legislation; Regulatory

August 21, 2024

/

Rita Agrela

Updates in the labelling of fragrance allergens in cosmetics

July 23, 2024

/

Verónica Pinho

New MDCG Guidance: Clinical evaluation of orphan medical devices

Regulatory

July 1, 2024

/

Rita Agrela

SCCS - Scientific Advice on Titanium dioxide (TiO2)

Legislation

April 29, 2024

/

Verónica Pinho

New MDCG guidance: Investigator’s Brochure and Summary of Safety and Performance Template

Legislation
Regulatory

August 21, 2024

/

Rita Agrela

Updates in the labelling of fragrance allergens in cosmetics

Legislation
Medical & Scientific

July 23, 2024

/

Verónica Pinho

New MDCG Guidance: Clinical evaluation of orphan medical devices

Regulatory
Legislation
Medical & Scientific

July 1, 2024

/

Rita Agrela

SCCS - Scientific Advice on Titanium dioxide (TiO2)

GMDP

June 13, 2024

/

Margarida Tapadas

The legal framework of medicinal cannabis in Portugal

OWL
Pharmacovigilance

May 27, 2024

/

Mariana Rocha

Desafios atuais de Farmacovigilância - Edição 2024

GMDP

May 20, 2024

/

Gustavo Sousa

Handling API manufacturers: Insights from the New CEFIC-APIC Guide and Owlpharma recent experience

Search & Filter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Clear all filters
GMDP, Legislation

Annex 1 - Manufacture of Sterile Medicinal Products

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

August 29, 2022

Read
OWL

PME Excelência '21

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

December 14, 2022

Read
OWL

knOWLedge – O programa de formações Owlpharma

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

April 27, 2023

Read
OWL, GMDP, Legislation

Anexo 1 - Mudanças e desafios no fabrico de medicamentos estéreis

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

May 2, 2023

Read
OWL

A new project – Future Headquarters

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

June 9, 2023

Read
OWL, GMDP

AuditSearch - Owlpharma's new tool

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

July 31, 2023

Read
OWL

DIA Marketplace

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

September 6, 2023

Read
Pharmacovigilance

Desafios atuais de Farmacovigilância - Edição 2023

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

September 21, 2023

Read
GMDP; Regulatory

MDR extension period – Where do you stand now?

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

September 22, 2023

Read
OWL, Pharmacovigilance

DESAFIOS ATUAIS DE FARMACOVIGILÂNCIA - Resumo da 1ª edição

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

November 23, 2023

Read
OWL, GMDP

GCP Audits - A new piece in our compliance puzzle

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

November 24, 2023

Read
OWL

Plano de formações knOWLedge 2024

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

January 16, 2024

Read
OWL, GMPD

Owlpharma becomes a member of the 3PARL

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

January 31, 2024

Read
OWL, Medical & Scientific, Pharmacovigilance

New HMA-EMA catalogues of real-world data sources and studies

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

February 23, 2024

Read
Legislation, Regulatory

Latest news on Advertisement of Medicinal Products in Digital Channels in Portugal

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

March 12, 2024

Read
Legislation , Medical & Scientific

Environmental Risk Assessment - The long-awaited updated guideline

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

April 8, 2024

Read
Legislation

New Decree-Law for Medical Devices in Portugal

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

April 15, 2024

Read
Legislation

New MDCG guidance: Investigator’s Brochure and Summary of Safety and Performance Template

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

April 29, 2024

Read
OWL

Fórum de Diretores Técnicos de Distribuição

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

May 17, 2024

Read
GMDP

Handling API manufacturers: Insights from the New CEFIC-APIC Guide and Owlpharma recent experience

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

May 20, 2024

Read
Owl; Pharmacovigilance

Desafios atuais de Farmacovigilância - Edição 2024

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

May 27, 2024

Read
GMDP

The legal framework of medicinal cannabis in Portugal

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

June 13, 2024

Read
Regulatory

SCCS - Scientific Advice on Titanium dioxide (TiO2)

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

July 1, 2024

Read

New MDCG Guidance: Clinical evaluation of orphan medical devices

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

July 23, 2024

Read
Legislation; Regulatory

Updates in the labelling of fragrance allergens in cosmetics

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

August 21, 2024

Read
Regulatory

New European Health Technology Assessment Framework for 2025

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

September 11, 2024

Read
OWL

Inauguração da nova sede

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

September 17, 2024

Read

World Patient Safety Day

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

September 17, 2024

Read

Owlpharma's Quality Management System - Certification ISO 9001:2015

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

October 4, 2024

Read
Regulatory, Legislation

Annual Price Revision for 2025

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

November 18, 2024

Read
Pharmacovigilance; Legislation

Risk Minimisation Measures - GVP Latest Updates

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

November 21, 2024

Read